Hallmarks of Cancer Flashcards
6 hallmarks of cancer
- immortality
- persistent proliferative signal
- inactivation of anti-proliferative signals
- resistance to cell death
- angiogenesis
- metastasis
what is immortality in relation to cancer
continuous cell division and limitless replication
what is replicative capacity?
the predetermined number of divisions in somatic cells
what governs replicative capacity?
- senescence
2. telomere length
what is senescence
a cell irreversibly exits the cell cycle but is still metabolically active
what causes a cell to go into senescence
cells measure cumulative physiologic stress that they experience over extended periods of time and stop proliferating once the damage exceeds threshold, such as accumulation of ROS
why is telomere length used for replative capacity?
telomere length is how the cell measures how many replicative generations it has passed through
how does a cell respond to ROS?
ROS causes DNA damage, but the cell repairs this by activating p53, which regulates p21 to inactivate Cdk
what sends a cell into senescence?
accumulated p21 (Cdk inhibitor)
happens during telomere shortening
a section of a telomere is lost during each cycle of replication at the 5’ end of the lagging strand due to lack of DNA upstream to ligate to
what occurs when there is insufficient telomerase activity?
prevention of addition of nucleotide repeats at the end of the chromosome
what occurs in the normal aging process of telomerase shortening and what happens in cancer cells?
telomeres in (somatic) cells become progressively shorter as we age, but some cancer cells can upregulate telomerase and increase or prevent the shortening of telomeres, 90% of human tumors are telomerase positive
what is a proto-oncogene
genes that encode proteins that function to receive or transmit cellular growth promoting signals, cause cell proliferation and survival in normal cells
what is an oncogene
GAIN OF FUNCTION MUTATIONS, when proto-oncogenes undergo a mutation that causes them to be ALWAYS ON (constitutive activation, inappropriate activation), leading to excessive cell survival and proliferation, most are dominant (only one allele has to be affected)
what are the main 3 proto-oncogenes?
growth factor receptors, Ras protein, Src kinase (could be anti-apoptotic proteins also)
what is the mitogenic pathway that is the most important in cancer pathogenesis?
Ras-MAPK, where the GF binds to RTK, RTK phosphorylates tyrosines attracting the adaptor protein Grb2, which recruits Sos (the Ras activating protein), which activates Ras, which phosphorylates Raf (MAPKKK), which phosphorylates MEK (MAPKK), which phosphorylates ERK (MAPK)
what is the prevalence of Ras mutation in cancers?
more than 20% of human tumors contain activating Ras mutations where Ras is always on
what is the prevalence of Raf mutation in cancers?
67% of melanomas contain activating Beta-Raf mutations, beta Raf always on to phosphorylate MEK and ERK for increased gene expression
what mutations can turn a proto-oncogene into an oncogene?
- mutation in coding sequence, causing a hyperactive protein made in normal amounts
- gene amplification causing a normal protein to be greatly overproduced
- chromosome rearrangement causing nearby regulatory DNA sequence to cause a normal protein to be over produced OR the chromosome fusion to actively transcribed gene produces a hyperactive fusion protein
what are the tumor suppressor genes?
Rb protein and p53 protein and Cdk inhibitors like p21 or p16^ink4a - loss of function
what allele combination do tumor suppressors have?
tumor suppressors are recessive, meaning both alleles have to be affected to cause abnormalities
difference between oncogene and tumor suppressor function?
oncogene is a gain of function mutation and tumor suppressor is a loss of function mutation
what is the two hit model?
- a mutation event (point mutation) inactivates one allele of a tumor suppressor, but unaffected allele can still function
- a second mutation event occurs that inactivates the unaffected allele, resulting in the complete functional elimination of the tumor suppressor gene (usually caused by a loss of heterozygosity)
what is the end result of inactivating the tumor suppressor genes?
excessive cell survival and proliferation
what is “loss of heterozygosity”
loss of normal function of one allele in a gene in which the the other allele was already inactivated, aka second hit in the two hit model of tumor suppressor gene inactivation, more likely to occur than a random mutation
what genetic events can eliminate tumor suppressor gene activity?
- a whole (normal) chromosome is lost
- a region containing the normal gene is deleted
- there is a loss of function mutation in the normal gene (LOH)
- normal gene activity is silenced by epigenetic changes (via methylation)
what is promoter methylation?
methylases covalently attach a methyl group to cytosine bases in promoter region of DNA, repressing the transcription of that gene, upregulation of methylases usually used in cancer to turn off tumor suppressor genes
how are cancer cells resistant to apoptosis?
- mutations in growth factor receptors make them constitutively active, never turning off even in absence of mitogens
- DNA damage response is not active, allowing for accumulation of genetic mutations - aka tumor suppressors (LOF) of pro-apoptotic proteins and p53 activating (oncogenes)(gain of function) anti-apoptotics
1/3 ways activated p53 evokes apoptotic response
induce expression of gene encoding FasR, causing display of Fas receptor on cell surface, sensitizing cell to any FasL in extracellular space
2/3 ways activated p53 evokes apoptotic response
induce expression of IGF-binding protein-3 (IGFBP-3) which is released into extracellular space, where it sequesters IGF-1 and IGF-2, which are prosurvival/anti-apoptotic signaling molecules
3/3 ways activated p53 evokes apoptotic response
induce expression of Bax, a pro-apoptotic protein that causes cytochrome C release from mitochondria (channel protein)
how would the loss of function (tumor suppressor) of p53 affect the cancer cell?
FasR would not be expressed on the cells, IGF-1 and IGF-2 would NOT be sequestered by IGFBP-3 and therefore would promote cancer cell survival and anti-apoptosis, Bax would not be expressed and NO mitochondrial channel pore would be formed
what is angiogenesis
new blood vessel formation
why is the cancer cell motivated to connect to circulatory system?
while the tumor grows, the inner cells are oxygen deprived and exposed to low nutrient levels, high levels of CO2, and high levels of metabolic waste, so cancer cell needs to find oxygen and nutrient source, and find a way to rid of waste and CO2
what is the angiogenic switch
when the cancer cells acquire the ability to induce growth of new blood vessels
how do cancer cells induce angiogenesis and what does that indicate?
cancer cells secrete VEGF (vascular endothelial growth factor), and the connection to blood vessels allow cancer cells to metastasize through the blood stream